|
End-of-day quote
Nasdaq
2026-10-01
|
5-day change | 1st Jan Change | ||
| 0.7441 USD | -4.88% |
|
-27.76% | -99.05% |
| 09-24 | SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. | CI |
| 09-24 | SRX Global Makes Investment in Onconetix | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.9M | - | - | - | - | - |
| 1,019B | |||||
| 617B | - | ||||
| 464B | |||||
| 356B | |||||
| 333B |
- Stock Market
- Stocks
- ONCO Stock
- Charts Onconetix, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
